切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - DCLK2 - Insulin and Insulin-like Receptors - HIV - HMG-CoA Reductases

13件产品中的 1-10

页面
每页
清除全部
  1. Mevastatin
    B1788 Mevastatin
    中文名: 美伐他汀
    Target: HMG-CoA Reductases
    Summary: HMG-CoA还原酶抑制剂
      ≥15.95 mg/mL
      insoluble in H2O
  2. Simvastatin (Zocor)
    A8522 Simvastatin (Zocor)
    中文名: 辛伐他汀
    Target: HMG-CoA Reductases
    Summary: HMGCR(HMG-CoA还原酶)抑制剂
      ≥20.95 mg/mL
      insoluble in H2O
  3. Pitavastatin Calcium
    A8504 Pitavastatin Calcium
     1 Citation
    中文名: 匹伐他汀钙
    Target: HMG-CoA Reductases
    Summary: 酶HMGCR抑制剂
      ≥34.85 mg/mL
      insoluble in H2O
  4. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O
  5. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/IR 选择性抑制剂
      ≥42.6 mg/mL
      insoluble in H2O
  6. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: 有效的、选择性的IGF-1R和InsR抑制剂
      ≥23.05 mg/mL
      insoluble in H2O
  7. MK 0893
    A3608 MK 0893
    Target: Insulin and Insulin-like Receptors|Glucagon Receptors
    Summary: 胰高血糖素受体/ IGF-1R拮抗剂
      ≥24.05 mg/mL
      insoluble in H2O
  8. LRRK2-IN-1
    A3558 LRRK2-IN-1
     1 Citation
    Target: LRRK2|DCLK2
    Summary: LRRK2抑制剂
      ≥28.55 mg/mL
      insoluble in H2O
  9. Betulinic acid
    A3237 Betulinic acid
    中文名: 白桦脂酸,桦木酸
    Target: Aminopeptidases|Topoisomerases|HIV
    Summary: 抗HIV和抗肿瘤化合物,五环三萜类化合物
      ≥22.85 mg/mL
      insoluble in H2O
  10. Pravastatin sodium
    A4369 Pravastatin sodium
    中文名: 普伐他汀钠
    Target: HMG-CoA Reductases
    Summary: HMG-CoA还原酶的高选择性和竞争性抑制剂
      ≥13.15 mg/mL
      ≥98.8 mg/mL

13件产品中的 1-10

页面
每页